CRYO CELL INTERNATIONAL INC (CCEL) — Institutional Holders, Q2 2026
12 institutional investment managers reported a CCEL position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.8M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
CCEL in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- FMRNew · +20,000 sh+$63.8K
- SUSQUEHANNA INTERNATIONAL GROUP, LLPAdded · +4,046 sh+$12.9K
- VANGUARD CAPITAL MANAGEMENTAdded · +3,452 sh+$11.0K
- GEODE CAPITAL MANAGEMENTAdded · +2,657 sh+$8.5K
- BARCLAYS PLCNew · +14 sh+$45.00
Biggest sellers
- BlackRockTrimmed · -7,287 sh-$23.2K
- UBS Group AGTrimmed · -356 sh-$1.1K
- SIGNATUREFDSold out · -100 sh-$319.00
CCEL 13F holders ranked 1–12 of 12
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | SFI Advisors#1 · 165,300 sh | 165,300 | $527.3K | 0.45% | 0.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT#2 · 164,976 sh | 164,976 | $526.3K | 0.00% | +2.1% |
| 3 | MassMutual Private Wealth & , FSB#3 · 111,035 sh | 111,035 | $354.2K | — | 0.0% |
| 4 | GEODE CAPITAL MANAGEMENT#4 · 46,273 sh | 46,273 | $147.7K | 0.00% | +6.1% |
| 5 | VANGUARD FIDUCIARY#5 · 23,346 sh | 23,346 | $74.5K | 0.00% | 0.0% |
| 6 | FMR#6 · 20,000 sh | 20,000 | $63.8K | 0.00% | New |
| 7 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#7 · 14,064 sh | 14,064 | $44.9K | 0.00% | +40.4% |
| 8 | BlackRock#8 · 6,696 sh | 6,696 | $21.4K | 0.00% | -52.1% |
| 9 | OSAIC#9 · 2,500 sh | 2,500 | $8.0K | 0.00% | 0.0% |
| 10 | MORGAN STANLEY#10 · 605 sh | 605 | $1.9K | 0.00% | +0.7% |
| 11 | UBS Group AG#11 · 316 sh | 316 | $1.0K | 0.00% | -53.0% |
| 12 | BARCLAYS PLC#12 · 14 sh | 14 | $45.00 | 0.00% | New |
Funds that sold out of CCEL in Q2 2026 (1)
Held CCEL at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| SIGNATUREFD100 sh | 100 | $355.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.